Preclinical CRO Market Is Likely To Up Demand At A USD 9.68 Billion By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjylFbuLdEdgvZgebL_HYBN0sVFCKTDeCFAYltOz8dA4WwH6amv249aXp-SYFG6GDEl1rsyqf0N2mx4vIsJNao59mGiy1638wa635Hb3FoAl6XViwM0o2bu6wqTKiJqH1iEV1tnOtOmsROmphTuHDG9jCZvKBbJz0iMc9jIlaMMtKk0iuWiiVgoZISd95dm/s320/Preclinical%20CRO%20Market.png)
San Francisco, 17 Jan 2024: The Report Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End Use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2023 - 2030 The global preclinical CRO market size is expected to reach USD 9.68 billion by 2030, expanding at a CAGR of 7.9%, according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trends. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the market during the forecast period. However, the COVID-19 pandemic had temporarily affected the market owing to the shutdown of research sites due to the implementation of national lockdowns. The market is undergoing a series of mergers and acquisitions, resulting in improvement in full-service capabilities and the internatio